The Use of Partial Fatty Acid Oxidation Inhibitors for Metabolic Therapy of Angina Pectoris and Heart Failure

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Herz

• Publication date

  2002-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00059-002-2428-xPMID 12439634
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oxygen consumption and substrate uptake of the hypertrophied rat heart in situ

  2005cited by this paper
• The effect of Oxfenicine on cardiac carbohydrate metabolism in intact dogs

  2005cited by this paper
• Control of cardiomyocyte gene expression as drug target

  2004cited by this paper
• Accelerated rates of glycolysis in the hypertrophied heart: are they a methodological artifact?

  2002cited by this paper
• Energy Metabolism in the Normal and Failing Heart: Potential for Therapeutic Interventions

  2002cited by this paper
• Role of USF1 phosphorylation on cardiac α-myosin heavy chain promoter activity

  2002cited by this paper
• Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis

  2002cited by this paper
• Palmitate-induced cardiac apoptosis is mediated through CPT-1 but not influenced by glucose and insulin.

  2002cited by this paper
• Phytanic acid, a natural peroxisome proliferator‐activated receptor agonist, regulates glucose metabolism in rat primary hepatocytes

  2002cited by this paper
• Partial fatty acid oxidation inhibitors for stable angina

  2002cited by this paper
• Metabolic Approaches to the Treatment of Ischemic Heart Disease: The Clinicians' Perspective

  2002cited by this paper
• Manipulations in glycogen metabolism and the failure to influence infarct size in the ischaemic rabbit heart.

  2002cited by this paper
• Role of USF1 phosphorylation on cardiac alpha-myosin heavy chain promoter activity.

  2002cited by this paper
• Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target

  2002cited by this paper
• Ligands of the peroxisome proliferator‐activated receptors (PPAR‐γ and PPAR‐α) reduce myocardial infarct size

  2002cited by this paper
• Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Inhibition of Cardiac Hypertrophy In Vitro and In Vivo

  2002cited by this paper
• Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.

  2002cited by this paper
• The use of ranolazine in cardiovascular disease

  2002cited by this paper
• Peroxisome proliferator-activated receptor-α activation and high-density lipoprotein metabolism☆

  2001cited by this paper
• Uncoupling protein 3 transcription is regulated by peroxisome proliferator‐activated receptor α in the adult rodent heart

  2001cited by this paper
• Postinfarction heart failure in rats is associated with upregulation of GLUT-1 and downregulation of genes of fatty acid metabolism.

  2001cited by this paper
• Reactivation of Peroxisome Proliferator-activated Receptor α Is Associated with Contractile Dysfunction in Hypertrophied Rat Heart*

  2001cited by this paper
• Attenuation of liver normothermic ischemia--reperfusion injury by preservation of mitochondrial functions with S-15176, a potent trimetazidine derivative.

  2001influential reference
• Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat.

  2001cited by this paper
• p38 Mitogen-activated Protein Kinase Activates Peroxisome Proliferator-activated Receptor α

  2001cited by this paper
• Chronic Catecholamine Depletion Switches Myocardium from Carbohydrate to Lipid Utilisation

  2001cited by this paper
• Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism.

  2001cited by this paper
• Effects of trimetazidine on the contractile response of chronically dysfunctional myocardium to low-dose dobutamine in ischaemic cardiomyopathy.

  2001cited by this paper
• The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.

  2000cited by this paper
• Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts with myocardial infarction

  2000cited by this paper
• Myosin heavy chain isoform expression in the failing and nonfailing human heart.

  2000cited by this paper
• Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes.

  2000cited by this paper
• Altered patterns of gene expression in response to myocardial infarction.

  2000influential reference
• Etomoxir-induced PPARα-modulated enzymes protect during acute renal failure

  2000influential reference
• Myocardial contractility after infarction and carnitine palmitoyltransferase I inhibition in rats.

  2000cited by this paper
• MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction.

  2000cited by this paper
• Elucidation of the Mechanism by Which (+)-Acylcarnitines Inhibit Mitochondrial Fatty Acid Transport*

  2000cited by this paper
• PPAR signaling in the control of cardiac energy metabolism.

  2000cited by this paper
• A nuclear complex containing PPARα/RXRα is markedly downregulated in the hypertrophied rat left ventricular myocardium with normal systolic function

  2000cited by this paper
• Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth.

  2000cited by this paper
• Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure.

  2000influential reference
• MET-88 a γ-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction

  2000cited by this paper
• Cardioprotective Effects of MET-88, a Gamma-Butyrobetaine Hydroxylase Inhibitor, on Cardiac Dysfunction Induced by Ischemia/Reperfusion in Isolated Rat Hearts

  2000cited by this paper
• Effect of perhexiline and oxfenicine on myocardial function and metabolism during low-flow ischemia/reperfusion in the isolated rat heart.

  2000cited by this paper
• Dichloroacetate improves postischemic function of hypertrophied rat hearts.

  2000cited by this paper
• Peroxisome proliferator‐activated receptors in the cardiovascular system

  2000cited by this paper
• Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.

  2000cited by this paper
• Modified heart-lung preparation for the evaluation of systolic and diastolic coronary flow in rats.

  2000cited by this paper
• First clinical trial with etomoxir in patients with chronic congestive heart failure.

  2000cited by this paper
• Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction.

  2000cited by this paper
• A nuclear complex containing PPARalpha/RXRalpha is markedly downregulated in the hypertrophied rat left ventricular myocardium with normal systolic function.

  2000cited by this paper
• Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction.

  2000cited by this paper
• Malonyl-CoA, fuel sensing, and insulin resistance.

  1999cited by this paper
• The role of the peroxisome proliferator-activated receptor alpha (PPAR alpha) in the control of cardiac lipid metabolism.

  1999cited by this paper
• Transcription of the SERCA2 gene is decreased in pressure-overloaded hearts: A study using in vivo direct gene transfer into living myocardium.

  1999cited by this paper
• The mechanism of inhibition of β-oxidation by aspirin metabolites in skin fibroblasts from Reye’s syndrome patients and controls

  1999cited by this paper
• The mechanism of inhibition of beta-oxidation by aspirin metabolites in skin fibroblasts from Reye's syndrome patients and controls.

  1999cited by this paper
• Functional and energetic consequences of chronic myocardial creatine depletion by beta-guanidinopropionate in perfused hearts and in intact rats.

  1999cited by this paper
• The role of the peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac lipid metabolism

  1999cited by this paper
• A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group.

  1999cited by this paper
• Beneficial effects of MET‐88 on left ventricular dysfunction and hypertrophy with volume overload in rats

  1999cited by this paper
• Phytanic Acid Activates the Peroxisome Proliferator-activated Receptor α (PPARα) in Sterol Carrier Protein 2-/ Sterol Carrier Protein x-deficient Mice*

  1999cited by this paper
• Transcriptional modulators targeted at fuel metabolism of hypertrophied heart.

  1999cited by this paper
• The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) gene promoter activity is decreased in response to severe left ventricular pressure-overload hypertrophy in rat hearts.

  1999cited by this paper
• Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure.

  1998influential reference
• Cardioprotective profile of MET‐88, an inhibitor of carnitine synthesis, and insulin during hypoxia in isolated perfused rat hearts

  1998cited by this paper
• Is the failing heart energy depleted?

  1998cited by this paper
• Regulation of cardiac alpha-myosin heavy chain gene transcription by a contractile-responsive E-box binding protein.

  1998cited by this paper
• Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.

  1998cited by this paper
• Differential influence of fasting and BM13.907 treatment on growth and phenotype of pressure overloaded rat heart

  1998cited by this paper
• Effects of dichloroacetate in patients with congestive heart failure

  1998cited by this paper
• Effects of trimetazidine on ischemic left ventricular dysfunction in patients with coronary artery disease.

  1998cited by this paper
• Effect of Trimetazidine on Carnitine Palmitoyltransferase-1 in the Rat Heart

  1998cited by this paper
• Ranolazine: a novel metabolic modulator for the treatment of angina.

  1998cited by this paper
• Metabolic alterations in the chronically denervated dog heart.

  1998cited by this paper
• Altered K+ current of ventricular myocytes in rats with chronic myocardial infarction.

  1998cited by this paper
• Control of Human Muscle-type Carnitine Palmitoyltransferase I Gene Transcription by Peroxisome Proliferator-activated Receptor*

  1998influential reference
• [Plasma hemostasis and biochemical indices in trimetazidine treatment of patients with chronic heart failure].

  1998cited by this paper
• Transcriptional regulation of metabolic processes: implications for cardiac metabolism

  1998cited by this paper
• 4-bromotiglic acid, a novel inhibitor of thiolases and a tool for assessing the cooperation between the membrane-bound and soluble beta-oxidation systems of rat liver mitochondria.

  1998cited by this paper
• Energy provision from glycogen, glucose, and fatty acids on adrenergic stimulation of isolated working rat hearts.

  1998cited by this paper
• Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor α*

  1998cited by this paper
• Long-term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6.

  1997cited by this paper
• A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program.

  1997cited by this paper
• Downregulation of sarcoplasmic reticulum Ca(2+)-ATPase during progression of left ventricular hypertrophy.

  1997cited by this paper
• Etomoxir improves left ventricular performance of pressure-overloaded rat heart.

  1997cited by this paper
• Combination treatment with trimetazidine and diltiazem in stable angina pectoris

  1997cited by this paper
• Protective effects of trimetazidine on hypoxic cardiac myocytes from the rat

  1997cited by this paper
• The sarco(endo)plasmic reticulum Ca(2+)-ATPase gene is regulated at the transcriptional level during compensated left ventricular hypertrophy in the rat.

  1997cited by this paper
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ

  1997cited by this paper
• Dichloroacetate as metabolic therapy for myocardial ischemia and failure.

  1997cited by this paper
• Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta.

  1997cited by this paper
• Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir

  1996cited by this paper
• Effect of nutritional state on substrate metabolism and contractile function in postischemic rat myocardium.

  1996cited by this paper
• Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

  1996cited by this paper
• Identification of a Contractile-responsive Element in the Cardiac -Myosin Heavy Chain Gene (*)

  1996cited by this paper
• Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts.

  1996cited by this paper
• Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone.

  1996influential reference
• Ranolazine increases active pyruvate dehydrogenase in perfused normoxic rat hearts: evidence for an indirect mechanism.

  1996cited by this paper
• Beneficial effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on energy metabolism in ischemic dog hearts.

  1996cited by this paper

• MICROBIAL METABOLITES REGULATE SOCIAL NOVELTY VIA CAMKII NEURONS IN THE BNST

  2025cites this paper
• Meldonium Improves Functional Capacity in Patients with Right Ventricular Failure

  2025cites this paper
• Mitochondrial fatty acid oxidation dysfunction impairs autophagic flux through ATP deficiency-caused lysosomal pH abnormity.

  2025cites this paper
• The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7

  2024cites this paper
• Fatty acid synthesis and oxidation regulate human endoderm differentiation by mediating SMAD3 nuclear localization via acetylation.

  2023cites this paper
• Microbial metabolites regulate social novelty via CaMKII neurons in the BNST.

  2023cites this paper
• The Material Basis and Mechanism of Xuefu Zhuyu Decoction in Treating Stable Angina Pectoris and Unstable Angina Pectoris

  2022cites this paper
• Structural analysis of the 2-oxoglutarate binding site of the circadian rhythm linked oxygenase JMJD5

  2022cites this paper
• Theranostic Nanomedicines for the Treatment of Cardiovascular and Related Diseases: Current Strategies and Future Perspectives

  2022cites this paper
• S-15176 Difumarate Salt Can Impair Mitochondrial Function through Inhibition of the Respiratory Complex III and Permeabilization of the Inner Mitochondrial Membrane

  2022cites this paper
• A Deep Insight Into Regulatory T Cell Metabolism in Renal Disease: Facts and Perspectives

  2022cites this paper
• The role of serum monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) in cardiovascular disease risk

  2021cites this paper
• КАРДИОПРОТЕКТОРНЫЕ ЭФФЕКТЫ СОЕДИНЕНИЯ АЛМ-802 НА МОДЕЛЯХ СУБЭНДОКАРДИАЛЬНОЙ ИШЕМИИ

  2021cites this paper
• Viral growth factor- and STAT3 signaling-dependent elevation of the TCA cycle intermediate levels during vaccinia virus infection

  2021cites this paper
• Efficient scale up of photochemical bromination of conjugated allylic compounds in continuous-flow

  2020cites this paper
• FOXO1 contributes to diabetic cardiomyopathy via inducing imbalanced oxidative metabolism in type 1 diabetes

  2020cites this paper
• Treatment of human skeletal muscle cells with inhibitors of diacylglycerol acyltransferases 1 and 2 to explore isozyme-specific roles on lipid metabolism

  2020cites this paper
• Impaired Metabolic Flexibility in the Osteoarthritis Process: A Study on Transmitochondrial Cybrids

  2020cites this paper
• AMPK Activation by Metformin Promotes Survival of Dormant ER+ Breast Cancer Cells

  2020influential citation
• The Vasorelaxant and Neuroprotective Effects of Mildronate in A Rabbit Subarachnoid Hemorrhage Model.

  2020cites this paper
• Neuroprotective effects of mildronate in a rat model of traumatic brain injury.

  2019cites this paper
• Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction

  2019cites this paper
• Carnitine Inborn Errors of Metabolism

  2019cites this paper
• Targeting Mitochondria for Therapy of Cardiovascular Disease

  2019cites this paper
• Role of Twist1 in metabolism of repeatedly stimulated Th1 cells

  2019cites this paper
• CDK9 Inhibition Induces a Metabolic Switch that Renders Prostate Cancer Cells Dependent on Fatty Acid Oxidation

  2019cites this paper
• Glucose metabolism and metabolic flexibility in cultured skeletal muscle cells is related to exercise status in young male subjects Running title : Enhanced glucose metabolism in myotubes from trained subjects

  2018cites this paper
• Whole grain intake associated molecule 5-aminovaleric acid betaine decreases β-oxidation of fatty acids in mouse cardiomyocytes

  2018cites this paper
• PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation

  2018cites this paper
• Pro-angiogenic Role of Danqi Pill Through Activating Fatty Acids Oxidation Pathway Against Coronary Artery Disease

  2018cites this paper
• Glucose metabolism and metabolic flexibility in cultured skeletal muscle cells is related to exercise status in young male subjects

  2018influential citation
• Trimetazidine and Other Metabolic Modifiers.

  2018cites this paper
• Loss of cardiac carnitine palmitoyltransferase 2 results in rapamycin-resistant, acetylation-independent hypertrophy

  2017cites this paper
• Advantages and Limitations of Current Biomarker Research: From Experimental Research to Clinical Application.

  2017cites this paper
• Metabolic Modulation with Incretins: Is the Bloom off the Rose?

  2017cites this paper
• Free fatty acids and cardiovascular outcome: a Chinese cohort study on stable coronary artery disease

  2017cites this paper
• eview harmacological effects of meldonium : Biochemical mechanisms and iomarkers of cardiometabolic activity

  2016cites this paper
• Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity.

  2016cites this paper
• The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines.

  2016cites this paper
• The effect of trimetazidine on ventricular repolarization indexes and left ventricular diastolic function in patients with coronary slow flow

  2016cites this paper
• Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update

  2016cites this paper
• Cardiac Metabolism – The Link to Clinical Practice

  2016cites this paper
• Kinetic and spectral properties of isovaleryl-CoA dehydrogenase and interaction with ligands.

  2015cites this paper
• The Effects of Difumarate Salt S-15176 after Spinal Cord Injury in Rats

  2015cites this paper
• Proteomics-Based Metabolic Modeling Reveals That Fatty Acid Oxidation (FAO) Controls Endothelial Cell (EC) Permeability*

  2015cites this paper
• Mildronate (Meldonium) in professional sports – monitoring doping control urine samples using hydrophilic interaction liquid chromatography – high resolution/high accuracy mass spectrometry

  2015influential citation
• Expression and purification of active, stabilized trimethyllysine hydroxylase.

  2014cites this paper
• Targeting carnitine biosynthesis: discovery of new inhibitors against γ-butyrobetaine hydroxylase.

  2014cites this paper
• Proteomics-based metabolic modelling reveals that fatty acid oxidation controls endothelial cell permeability

  2014cites this paper
• Fatty acid oxidation: systems analysis and applications

  2013cites this paper
• Acetyl-l-Carnitine and Oxfenicine on Cardiac Pumping Mechanics in Streptozotocin-Induced Diabetes in Male Wistar Rats

  2013cites this paper
• Targeting the Mitochondria in Cardiovascular Diseases

  2013cites this paper
• Targeting myocardial metabolism for the treatment of stable angina.

  2013cites this paper
• Molecular Dissection of Cyclosporin A’s Neuroprotective Effect Reveals Potential Therapeutics for Ischemic Brain Injury

  2013cites this paper
• Effect of Chronic CPT-1 Inhibition on Myocardial Ischemia-Reperfusion Injury (I/R) in a Model of Diet-Induced Obesity

  2012cites this paper
• Molecular, Clinical and Environmental Toxicology

  2012cites this paper
• A personalized life: biomarker monitoring from cradle to grave.

  2012cites this paper
• Efficacy of Metabolic Modulators in Ischemic Heart Disease: An Overview

  2012cites this paper
• Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

  2011cites this paper
• Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axis.

  2011cites this paper
• Modulating fatty acid oxidation in heart failure.

  2011cites this paper
• [Clinico-economical aspects of application of trimetazidine MB in patients with chronic heart failure and cardiac rhythm disturbances].

  2011cites this paper
• Effects of acetyl‐L‐carnitine and oxfenicine on aorta stiffness in diabetic rats

  2010cites this paper
• The effect of CPT-1 inhibition on myocardial function and resistance to ischemia/reperfusion injury in a rodent model of the metabolic syndrome

  2010cites this paper
• Bioenergetics and Metabolic Changes in the Failing Heart

  2010cites this paper
• Myocardial fatty acid metabolism in health and disease.

  2010cites this paper
• Sarcolemmal fatty acid uptake vs. mitochondrial beta-oxidation as target to regress cardiac insulin resistance.

  2009cites this paper
• Mildronate, a Regulator of Energy Metabolism, Reduces Atherosclerosis in apoE/LDLR–/– Mice

  2009cites this paper
• Fatty acid oxidation and meiotic resumption in mouse oocytes

  2009cites this paper
• Renal protective effect of metabolic therapy in patients with coronary artery disease and diabetes: from bench to bed side.

  2009cites this paper
• Myocardial Infarct Size-Limiting and Anti-Arrhythmic Effects of Mildronate Orotate in the Rat Heart

  2009cites this paper
• Metabolic remodelling of the failing heart: beneficial or detrimental?

  2009cites this paper
• The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.

  2009cites this paper
• Impaired energetics in heart failure - a new therapeutic target.

  2008cites this paper
• Metabolic remodelling of the failing heart: beneficial or detrimental?

  2008cites this paper
• The PPARα-PGC-1α Axis Controls Cardiac Energy Metabolism in Healthy and Diseased Myocardium

  2007cites this paper
• CHAPTER 16 – Fatty Acid and Glucose Metabolism in Cardiac Disease

  2007cites this paper
• Extracellular glycerol regulates the cardiac energy balance in a working rat heart model.

  2007influential citation
• The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.

  2007cites this paper
• The PPAR regulatory system in cardiac physiology and disease.

  2007cites this paper
• Mildronate: an antiischemic drug for neurological indications.

  2006cites this paper
• Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth

  2006cites this paper
• Současný stav a perspektivy léčby chronického srdečního selhání

  2006cites this paper
• The Cardiac Fatty Acid Metabolic Pathway in Heart Failure

  2006cites this paper
• Metabolic modulation of myocardial ischemia

  2006cites this paper
• Metabolic approach in heart failure: rethinking how we translate from theory to clinical practice.

  2006cites this paper
• Pharmacologyonline 1 : 1-18 ( 2006 ) Sjakste and Kalvinsh 1 MILDRONATE : AN ANTIISCHEMIC DRUG WITH MULTIPLE INDICATIONS

  2006cites this paper
• Cardiac energy metabolism alterations in angiotensin II induced hypertrophy.

  2006cites this paper
• Regulation of the sarcoplasmic reticulum Ca2+-ATPase expression in the hypertrophic and failing heart.

  2006cites this paper
• MILDRONATE: AN ANTIISCHEMIC DRUG WITH MULTIPLE INDICATIONS

  2006cites this paper
• Targeted drug delivery to mammalian mitochondria in living cells

  2005cites this paper
• Free radical scavenging of xanthones from Swertia chirata Buchham and tumor cell growth inhibition

  2005cites this paper
• Plasma free fatty acids and peroxisome proliferator-activated receptor alpha in the control of myocardial uncoupling protein levels.

  2005cites this paper
• HIGH‐FAT DIET PREVENTS CARDIAC HYPERTROPHY AND IMPROVES CONTRACTILE FUNCTION IN THE HYPERTENSIVE DAHL SALT‐SENSITIVE RAT

  2005cites this paper
• Myocardial substrate metabolism in the normal and failing heart.

  2005cites this paper
• [Metabolism and the hypertrophied heart of the elderly].

  2005cites this paper
• Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure.

  2005influential citation
• Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.

  2005cites this paper
• Stoffwechsel und hypertrophiertes Altersherz

  2005cites this paper
• Effectors of fatty acid oxidation reduction: promising new anti-ischaemic agents.

  2005cites this paper